10-Hydroxy Aconitine(CAS: 41849-35-8)

10-Hydroxy Aconitine is subject to regulatory guidelines such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the EU, and FDA and EPA requirements in the US. These guidelines cover classification, labeling, and safety data sheet (SDS) requirements, as well as restrictions on handling and disposal.

There are several alternatives to 10-Hydroxy Aconitine in synthesis, including its analogs like 12-Hydroxy Aconitine and cis-10-Hydroxy Aconitine, and isomers. Common alternative reagents include other aconitine derivatives and natural products, which can serve as effective substitutes depending on the specific application.

The market and research trends for 10-Hydroxy Aconitine show growing interest in its potential medicinal applications, particularly in pain management and anti-cancer research. There is a focus on developing more targeted and safer formulations, driven by increasing demand and advances in synthetic chemistry and pharmacology.

Waste containing 10-Hydroxy Aconitine should be handled according to regulatory guidelines, such as GHS and REACH. It should be collected in appropriate containers, labeled with hazard warnings, and disposed of through professional waste disposal services. Environmental protection precautions include ensuring no direct release into the environment and proper incineration or chemical treatment to neutralize the compound.